LY 573636,
LY-573636,
LY573636,
LY573636 sodium,
N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide,
tasisulam,
Tasisulam,
519055-62-0,
LY573636,
N-(2,4-Dichlorobenzoyl)-5-bromothiophene-2-sulfonamide,
UNII-1YC4W9MSLJ,
LY 573636,
LY-573636,
1YC4W9MSLJ,
N-(5-bromothiophen-2-ylsulfonyl)-2,4-dichlorobenzamide,
N-((5-BROMOTHIOPHEN-2-YL)SULFONYL)-2,4-DICHLOROBENZAMIDE,
Tasisulam [INN],
N-[(5-bromothiophen-2-yl)sulfonyl]-2,4-dichlorobenzamide,
C11H6BrCl2NO3S2,
Tasisulam(LY573636),
Tasisulam (LY573636),
SCHEMBL1581371,
CHEMBL2110587,
DTXSID20199869,
HMS3653O12,
AOB87365,
BCP05154,
EX-A1367,
ZINC3816311,
MFCD11973637,
s7326,
AKOS027250790,
API0005245,
BCP9000890,
DB11941,
QC-5973,
RL03913,
SB19401,
VT20431,
NCGC00386305-05,
AK175844,
AN-16682,
AS-38576,
BC294277,
AB0032518,
FT-0763021,
SW219181-1,
X5833,
055T620,
J-522818,
N-[(5-bromo-2-thienyl)sulfonyl]-2,4-dichloro-benzamide,
Z442229142,
Benzamide, N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichloro-,
cc-591,
CID10160238,
B1422,
A13070,
N-(5-bromothiophen-2-yl)sulfonyl-2,4-dichloro-benzamide,
519055-63-1,